FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

NCT04169347 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: Oxaliplatin

Sponsor

Criterium, Inc.

Collaborators

[object Object]